“With the Oculenz the idea is that the patient senses the entire image and learns to disregard the defect area through “neural adaptation” due to the “plasticity of the brain,” said Dr. R. Wade Crow, M.D., Neuro Ophthalmologist and Assistant Professor of Neuro-Ophthalmology at the University of California-Irvine and member of the Ocutrx IMAB, “Working with visual input, the brain can train itself to not see redundant or unnecessary things.”
Dr. Thoma Finley, MDTulsa Retina ConsultantsOcutrx IMAB Chairman
Dr. Lars Freisberg, MDTulsa Retina Consultants
Dr. Diane Whitaker, ODDuke University Medical Staff
Dr. Michael A. Albert, Jr., MDRetina Consultants of Alabama, P.C.
Dr. Thomas Finley, M.D. is a Vitreoretinal Surgeon who practices with the Tulsa Retina Consultants in Tulsa, Oklahoma. He graduated from the University of Oklahoma Medical School, and completed his graduate practice with the University of Alabama UAB Hospital, having completed his undergraduate degree from Cameron University. Dr. Finley was board Certified in Ophthalmology in 2011. In 2015, Dr. Finley and Dr. Lars Freisberg came together to create Tulsa Retina Consultants. Today, it’s the region’s largest group of retina specialists with over 15,000 patients.
Dr. Lars Freisberg is an ophthalmologist in Tulsa, Oklahoma. He received his medical degree from Philipps University of Marburg Faculty of Medicine and has been in practice for more than 20 years. Dr. Freisberg is board certified in Opthalmogy in the United States, Germany and Norway. Dr. Freisberg specializes in diabetic retinopathy. In addition to retinopathy, some of the more common retinal conditions Dr. Freisberg treats are macular degeneration, retinal detachment, and flashes and floaters. However, he’s always willing to dig in to less typical cases to find the best solution. “Unusual situations that require cooperation with other colleagues are always a challenge. I find calling upon the retina community to find the best possible solution for my patient to be very rewarding.”
Dr. Freisberg is one of the founding members of Tulsa Retina Consultants and looks forward to expanding access to care to patients across northeast Oklahoma.
Dr. Diane Whitaker, O.D., is the Division Chief of Vision Rehabilitation and Performance at Duke University Eye Center, Assistant Professor of Ophthalmology, Duke School of Medicine, Clinical Program Director, Duke Sports Vision Center. Her past experience includes specialty low vision training at the Lighthouse for the Blind in Houston, Texas and providing vision rehabilitation services at the UNC Department of Ophthalmology from 2001-2006. In 2015 she was named an Innovator and one of the Most Influential Women in Optical. In 2017, she received the InSightful Visionary BVI Champion Award and served as the Medical Chair for the Foundation for Fighting Blindness Triangle Vision walk which successfully raised over $120,000 to fund research to prevent blindness.
Dr. Michael A. Albert, Jr., M.D. is a vitreoretinal surgeon with Retina Consultants of Alabama, P.C. at the University of Alabama at Birmingham Callahan Eye Hospital and is an Associate Professor with the UAB Department of Ophthalmology. Dr. Albert received his undergraduate degree from the University of Virginia, graduated with honors from the West Virginia University School of Medicine, and completed his residency and surgical fellowship with the UAB Department of Ophthalmology. He is a recipient of the Senior Honor Award from both the American Academy of Ophthalmology and the American Society of Retina Specialists for having authored and co-authored numerous journal articles, for having participated in several clinical trials, and for having presented scientific platform presentations and instructional courses at state, national, and international ophthalmology societal meetings. His areas of practice include the diagnostic evaluation, medical treatment, and surgical management of diseases of the vitreous, retina, macula, and choroid. Dr. Albert also enjoys the privilege of training ophthalmology residents and vitreoretinal surgical fellows at his institution.
Dr. Sumit Garg, MDGavin Herbert Eye Institute
Dr. R. Wade Crow, MDHerbert Eye Institute
Dr. Patrick D. Yoshinga, ODSoCal School of Optometry
Dr. Hugo Mercado, MD Mexico City, Retinal Surgeon
Dr. Garg is an Assistant Clinical Professor at the Department of Ophthalmology, Gavin Herbert Eye Institute, University of California-Irvine. He also serves as Medical Director at the Gavin Herbert Eye Institute, and Vice Chair of Clinical Ophthalmology at the Department of Ophthalmology University of California-Irvine. Dr. Garg has been recognized as one of the Best Doctors in America® (Ophthalmology, 2013, 2015, 2016), won the award for Physicians of Excellence, Orange County Medical Association, 2015-2018, and was noted as a Top Ophthalmologist by the International Association of Healthcare Professionals (IAHCP)
Dr. Robert Crow is a neuro-ophthalmologist in Irvine, California and is affiliated with the Gavin Herbert Institute of the University of California-Irvine, and is associated with UC Irvine Medical Center and VA Long Beach Healthcare System. He received his medical degree from Keck School of Medicine of USC and has been in practice 20 years. Dr. Crow has won numerous awards, including the Best of LA 2013 - Ophthalmology award, the UC Irvine 2012 "Heroes in Healthcare" Finalist, 2012 Recognition for Outstanding Teaching Service Award University of California, a 2011 Nomination for the Stanley van den Noort & Elliot Frohman Mentoring Award, 2007 Clinical Instructor of the Year award, the 2002 McKibben Distinguished Scholar Award (Scholarship awarded by the USC School of Medicine).
Dr. Patrick D. Yoshinaga received the Doctor of Optometry degree from the Southern California College of Optometry in 1983. He has enjoyed working in private practice since 1987 and has served as Director of Contact Lens Services at the University of Southern California Doheny Eye Institute. He worked at the Doheny Eye Institute from 1984 to 2000 with special emphasis in the areas of contact lens fitting of post-surgical patients and for the treatment of ocular disease, and low vision rehabilitation.
Dr. Yoshinaga is currently Associate Professor at Southern California College of Optometry and teaches in the clinical departments of Primary Care and Low Vision Rehabilitation. He also teaches in geometric optics, ophthalmic optics, and low vision laboratories. Dr. Yoshinaga is the coordinator of the Las Vegas Low Vision Clinic; State of Nevada Bureau of Services to the Blind and Visually Impaired. He has been a Fellow of the American Academy of Optometry since 1986.
Director of Research, Asociación para Evitar la Ceguera en México
Professor of Ophthalmology, University of Colorado School of Medicine
Ophthalmologist, Hospital Médica Sur
Vitreo-retina surgeon. Asociación Para Evitar la Ceguera en México, I.A.P.
Dr. Hugo Quiroz-Mercado is a retina specialist expert in diabetic retinopathy and retinopathy of prematurity for 8 years he served as Director of Ophthalmology Service at Denver Health Medical Center. With over 25 years of practice experience, Dr. Quiroz-Mercado has held previous appointments as the Director of the Retina Department and Chief of the Experimental Surgery Laboratory at Luis Sanchez Hospital for the Prevention of Blindness, as well as a professor of Ophthalmology at the Facultad de Medicine Universidad Autonoma de Mexico. He specializes in treating patients with severe retinopathy and helping them cope with the impending complications. He has participated in multiple clinical and preclinical research collaborating with several Universities like Stanford and University of Colorado. He has published more than 100 peer reviewed papers and 5 books on vitreo-retinal diseases and founder of PACORES (Pan-American Collaborative Retina Research Group).
Dr. Quiroz-Mercado completed his medical degree at Facultad de Medicine Universidad Nacional Autonoma de Mexico, and completed his postgraduate residency at Luis Sanchez Hospital for the Prevention of Blindness in Mexico City. Dr. Quiroz-Mercado then furthered his training by completing fellowships in Vitreo-Retinal Diseases at APEC in Mexico City and Schepens Eye Research Institute in Boston.
“The Oculenz is the first ground-breaking technology to offer a solution for advanced central visual defects in patients with retinal disease,” said Dr. Thomas Finley, M.D. a Vitreoretinal surgeon and member of the Ocutrx International Medical Advisory Board (IMAB).